Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Public ClinicalTrials.gov record NCT01272791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Phase 2 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer
Study identification
- NCT ID
- NCT01272791
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Peregrine Pharmaceuticals
- Industry
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Interventions
- Gemcitabine Drug
- bavituximab Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2010
- Primary completion
- Jan 31, 2013
- Completion
- Feb 28, 2013
- Last update posted
- Apr 18, 2017
2011 – 2013
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer & Research Centers | Chandler | Arizona | 85224 | — |
| Moores UCSD Cancer Center | La Jolla | California | 92093 | — |
| Lynn Cancer Institute | Boca Raton | Florida | 33486 | — |
| John B. Amos Cancer Center | Columbus | Georgia | 31904 | — |
| The Cancer Center at DeKalb Medical | Decatur | Georgia | 30033 | — |
| Northeast Georgia Medical Center | Gainesville | Georgia | 30501 | — |
| Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler | Savannah | Georgia | 31405 | — |
| Joliet Oncology-Hematology Associates, Ltd. | Joliet | Illinois | 60435 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Arena Oncology Associates, PC | Lake Success | New York | 11042 | — |
| Leo W. Jenkins Cancer Center - East Carolina University | Greenville | North Carolina | 27834 | — |
| St. Luke's Cancer Center | Bethlehem | Pennsylvania | 18015 | — |
| Vasicek Cancer Center at Scott & White Memorial Hospital | Temple | Texas | 76508 | — |
| Lynchburg Hematology-Oncology Clinic | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01272791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2017 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01272791 live on ClinicalTrials.gov.